v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Apr. 30, 2026
Apr. 30, 2025
Current assets    
Cash and cash equivalents $ 99,710 $ 237,595
Short-term investments 96,724  
Accounts receivable, net 14,542 8,081
Disposable medical equipment supplies 6,706 6,572
Prepaid expenses and other current assets 4,677 3,080
Total current assets 222,359 255,328
Long-term investments 65,767  
Right-of-use assets 3,364 2,078
Deposits 1,761 2,021
Restricted cash 334 334
Property and equipment, net 59,090 34,830
Other long-term assets 5,790 1,153
Total assets 358,465 295,744
Current liabilities    
Accounts payable 27,295 23,961
Accrued liabilities 23,046 13,829
Operating lease liabilities, current portion 31 187
Total current liabilities 50,372 37,977
Operating lease liabilities, net of current portion 4,111 3,026
Warrant liabilities 1,369 8,097
Other long-term liabilities 306 140
Long-term debt, net 42,649 41,098
Total liabilities 98,807 90,338
Commitments and contingencies (Note 14)
Shareholders' equity    
Common Shares, $1.00 par value; 100,000,000 shares authorized as of April 30, 2026 and April 30, 2025; 58,383,924 issued and outstanding as of April 30, 2026 and 51,348,656 shares issued and outstanding as of April 30, 2025 58,384 51,349
Additional paid-in capital 853,353 674,306
Accumulated other comprehensive loss (218)  
Accumulated deficit (651,861) (520,249)
Total shareholders' equity 259,658 205,406
Total liabilities and shareholders' equity $ 358,465 $ 295,744